HLB INC. Logo

HLB INC.

A biopharmaceutical company developing new global anti-cancer drugs.

028300 | KO

Overview

Corporate Details

ISIN(s):
KR7028300002
LEI:
Country:
South Korea
Address:
세종특별자치시 연동면 명학산단서로 10-5, 세종특별자치시

Description

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-18 00:00
주주명부폐쇄기간또는기준일설정
Korean 5.0 KB
2025-09-18 00:00
증권신고서(합병)
Korean 5.0 MB
2025-09-17 00:00
[첨부추가]주요사항보고서(회사합병결정)
Korean 42.9 KB
2025-09-16 00:00
주식등의대량보유상황보고서(일반)
Korean 129.4 KB
2025-09-08 00:00
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 11.2 KB
2025-09-03 00:00
[기재정정]주식매수선택권부여에관한신고
Korean 41.0 KB
2025-09-01 00:00
주식등의대량보유상황보고서(일반)
Korean 138.5 KB
2025-09-01 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-28 00:00
증권발행결과(자율공시)
Korean 5.6 KB
2025-08-28 00:00
지속가능경영보고서등관련사항(자율공시)
Korean 11.1 KB
2025-08-20 00:00
주요사항보고서(전환사채권발행결정)
Korean 43.1 KB
2025-08-13 00:00
반기보고서 (2025.06)
Korean 3.8 MB
2025-08-01 00:00
[기재정정]주요사항보고서(회사합병결정)
Korean 47.6 KB
2025-08-01 00:00
기타경영사항(자율공시) (회사합병결정 철회에 관한 사항)
Korean 7.9 KB
2025-08-01 00:00
철회신고서
Korean 4.6 KB

Automate Your Workflow. Get a real-time feed of all HLB INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.